104 related articles for article (PubMed ID: 15837583)
1. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q.
Veerhuis R; Boshuizen RS; Morbin M; Mazzoleni G; Hoozemans JJ; Langedijk JP; Tagliavini F; Langeveld JP; Eikelenboom P
Neurobiol Dis; 2005; 19(1-2):273-82. PubMed ID: 15837583
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.
Familian A; Boshuizen RS; Eikelenboom P; Veerhuis R
Glia; 2006 Feb; 53(3):233-40. PubMed ID: 16220550
[TBL] [Abstract][Full Text] [Related]
4. Minocycline does not affect amyloid beta phagocytosis by human microglial cells.
Familian A; Eikelenboom P; Veerhuis R
Neurosci Lett; 2007 Apr; 416(1):87-91. PubMed ID: 17317005
[TBL] [Abstract][Full Text] [Related]
5. Fibrillar prion peptide (106-126) and scrapie prion protein hamper phagocytosis in microglia.
Ciesielski-Treska J; Grant NJ; Ulrich G; Corrotte M; Bailly Y; Haeberle AM; Chasserot-Golaz S; Bader MF
Glia; 2004 Apr; 46(2):101-15. PubMed ID: 15042579
[TBL] [Abstract][Full Text] [Related]
6. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
7. Complement component C1q modulates the phagocytosis of Abeta by microglia.
Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ
Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279
[TBL] [Abstract][Full Text] [Related]
8. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
Sjöberg AP; Nyström S; Hammarström P; Blom AM
Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
[TBL] [Abstract][Full Text] [Related]
9. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.
Ricchelli F; Buggio R; Drago D; Salmona M; Forloni G; Negro A; Tognon G; Zatta P
Biochemistry; 2006 May; 45(21):6724-32. PubMed ID: 16716083
[TBL] [Abstract][Full Text] [Related]
10. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.
Pisalyaput K; Tenner AJ
J Neurochem; 2008 Feb; 104(3):696-707. PubMed ID: 17986223
[TBL] [Abstract][Full Text] [Related]
11. Amyloid associated proteins in Alzheimer's and prion disease.
Veerhuis R; Boshuizen RS; Familian A
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
[TBL] [Abstract][Full Text] [Related]
12. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
[TBL] [Abstract][Full Text] [Related]
13. Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits.
Colucci M; Moleres FJ; Xie ZL; Ray-Chaudhury A; Gutti S; Butefisch CM; Cervenakova L; Wang W; Goldfarb LG; Kong Q; Ghetti B; Chen SG; Gambetti P
J Neuropathol Exp Neurol; 2006 Jul; 65(7):642-51. PubMed ID: 16825951
[TBL] [Abstract][Full Text] [Related]
14. Fibrillar prion peptide PrP(106-126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.
Gavín R; Ureña J; Rangel A; Pastrana MA; Requena JR; Soriano E; Aguzzi A; Del Río JA
Neurobiol Dis; 2008 May; 30(2):243-54. PubMed ID: 18374587
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration.
Garção P; Oliveira CR; Agostinho P
J Neurosci Res; 2006 Jul; 84(1):182-93. PubMed ID: 16634056
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
17. Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins.
Nielsen HM; Mulder SD; Beliën JA; Musters RJ; Eikelenboom P; Veerhuis R
Glia; 2010 Aug; 58(10):1235-46. PubMed ID: 20544859
[TBL] [Abstract][Full Text] [Related]
18. Complement protein C1q recognizes a conformationally modified form of the prion protein.
Blanquet-Grossard F; Thielens NM; Vendrely C; Jamin M; Arlaud GJ
Biochemistry; 2005 Mar; 44(11):4349-56. PubMed ID: 15766264
[TBL] [Abstract][Full Text] [Related]
19. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
[TBL] [Abstract][Full Text] [Related]
20. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
Yang L; Zhou X; Yang J; Yin X; Han L; Zhao D
J Neuroimmunol; 2008 Aug; 199(1-2):10-7. PubMed ID: 18547651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
